Streetbeat News

Revenues

PRLB

Protolabs (NYSE:PRLB) has rebranded its manufacturing partner network from Hubs to Protolabs Network, offering expanded capabilities and a unified customer experience. The rebranding follows significant growth since acquiring the Amsterdam-based network in 2021, with an 80% year-over-year revenue increase in Q3 2023 through the network. The Protolabs Network, with over 250 partners, aims to provide resources for the entire product life cycle, offering benefits like tighter tolerances, enhanced finishing, and higher volumes at lower costs. The move emphasizes a hybrid digital manufacturing model that combines Protolabs' internal capabilities with the global network.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:31 pm

FNA

Paragon 28 announced preliminary Q4 revenue of $60.3M-$60.6M, surpassing the estimate of $52.09M. The company also provided preliminary 2023 revenue guidance of $216.1M-$216.4M, which is in line with the estimated $216.09M.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:30 pm

PTCT

PTC Therapeutics projects its FY23 revenue to be approximately $946 million, slightly above the consensus estimate of $936.85 million.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:30 pm

CTKB

Cytek Biosciences, Inc. (NASDAQ:CTKB) announced preliminary, unaudited FY23 revenue results, expecting to be near the high end of its $188M-$192M guidance range. The results are subject to year-end closing and audit adjustments. Cytek will provide finalized Q4 and FY23 results and 2024 guidance in an earnings call by end of February 2024. The announcement comes ahead of CEO Wenbin Jiang's presentation at the J.P. Morgan Healthcare Conference.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:30 pm

MMSI

Merit Medical Systems Inc. has reported preliminary revenue for 2023 in the range of $1.255 billion to $1.259 billion, which is slightly above the estimated $1.25 billion.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:26 pm

AAPL

Apple announced the Apple Vision Pro, a spatial computer available in U.S. Apple Stores and online from February 2, with pre-orders starting January 19. Vision Pro offers a new way of interacting with digital content through visionOS and supports over 1 million iOS and iPadOS apps. It features a three-dimensional interface, eye, hand, and voice control, and new experiences in productivity, entertainment, gaming, and personal memories. It also introduces a new videoconferencing experience with Persona and is designed with environmental considerations. The starting price is $3,499, with additional accessories available for purchase.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:25 pm

APLS

Apellis Pharmaceuticals reported preliminary Q4 net product revenues of $138M for SYFOVRE and EMPAVELI and expects 2023 product revenues of $366M for the same products.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:24 pm

WGS

GeneDx Holdings Corp. (NASDAQ:WGS) announced preliminary financial results for Q4 and FY 2023, exceeding revenue expectations. Q4 revenue is expected to be at least $58M, surpassing the $49.06M estimate, and FY23 revenue is projected to be at least $203M, above the $188.3M estimate. The company reported significant year-over-year growth in exome and genome test revenue and reduced cash burn. GeneDx reiterates its path to profitability by 2025 and will discuss detailed financial and operating results in a conference call on February 20, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:14 pm

SCLX

Scilex Holding announced plans for FY24 to expand its product lineup and candidates, aiming to surpass $200M in gross sales.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:14 pm

TXG

10x Genomics has announced preliminary Q4 revenue of $184M, surpassing the estimate of $179.7M. Additionally, the company's preliminary revenue for 2023 is reported at $618.7M, which also exceeds the estimated $614.69M.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:13 pm